As part of our Cell-based Therapies research group, Nefertiti investigates pro-regenerative bioactive factors derived from the human amniotic membrane and evaluates their impact on tissue regeneration signaling pathways. The use of these bioactive factors, instead of cells, might facilitate more specific and effective therapeutic interventions in the future.